Question 1

Has John Earl received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $4,745,116 in general payments to John Earl across 789 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean John Earl did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about John Earl come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Pfizer	187	$3,187,414
GSK	394	$778,151
Novo Nordisk AS	72	$241,660
Regeneron	28	$222,540
AstraZeneca	5	$111,001
Boehringer Ingelheim	6	$47,348
Esperion Therapeutics, Inc.	59	$39,120
Astrazeneca UK Limited	2	$35,582
Kowa Research Institute, Inc.	22	$30,105
Janssen Research & Development, LLC	3	$24,264
Sanofi US Services Inc.	6	$15,853
Novartis	3	$7,218
Lexicon Pharmaceuticals, Inc.	2	$4,860

John Earl

Payments from drug & device makers

Who reported the general payments

How this compares

Other family medicine in Hickory